Genetic Technologies Stock Price, News & Analysis
Company Description
Genetic Technologies (NASDAQ: GENE) is a publicly traded testing laboratories company in the Professional, Scientific, and Technical Services sector. The company has a market capitalization of $3.7M, ranking #6,813 among all listed U.S. companies by market cap.
GENE stock has declined 78.0% over the past year. Shares last traded at $0.7650.
This page provides a comprehensive overview of GENE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Genetic Technologies (GENE) stock last traded at $0.7650. Over the past 12 months, the stock has lost 78.0%. At a market capitalization of $3.7M, GENE is classified as a micro-cap stock with approximately 4.8M shares outstanding.
Latest News
Genetic Technologies has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include management. View all GENE news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
GENE Company Profile & Sector Positioning
Genetic Technologies (GENE) operates in the Testing Laboratories industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.